Chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer patients: is it time for additional evidence?

Recent efforts to improve survival in patients with locally advanced esophageal carcinoma have combined both systemic and local therapy. However, the role of neoadjuvant chemoradiotherapy in technically operable IIa-III esophageal carcinoma is still unresolved.

Detalles Bibliográficos
Autores principales: Cafarotti, Stefano, Cesario, Alfredo, Porziella, Venanzio, Margaritora, Stefano, Granone, Pierluigi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103440/
https://www.ncbi.nlm.nih.gov/pubmed/21504620
http://dx.doi.org/10.1186/1477-7819-9-41
Descripción
Sumario:Recent efforts to improve survival in patients with locally advanced esophageal carcinoma have combined both systemic and local therapy. However, the role of neoadjuvant chemoradiotherapy in technically operable IIa-III esophageal carcinoma is still unresolved.

Ejemplares similares